Bruce Gil

BioAge Labs is developing weight loss drugs by targeting "the biology of human aging"

Oura is partnering with Dexcom, which recently released a continuous glucose monitor

Costco voluntarily recalled some of its butter products because they were missing a "contains milk" label

Discover A pharma company hiked the price of its eye drug by a whopping 486%

It's the CEO's first major sale of Warner Bros. Discover stock since the merger of WarnerMedia and Discovery communications

Harvard professor Timothy Springer owns about 16% of Morphic, a company Eli Lilly is buying for $3.2 billion

Plus: three ways Big Tech is vulnerable to tariff retaliation

HHS Secretary Kennedy says updated dietary guidelines will prioritize public health over special interests

Plus: three ways Big Tech is vulnerable to tariff retaliation

Plus: three ways Big Tech is vulnerable to tariff retaliation

The pharma giant just sued two compounding pharmacies for making off-brand versions of Zepbound

U.S. brands face rising costs and potential price hikes as major suppliers — China and Vietnam — face steep levies

Plus: Chipotle’s avocado hunt

The digital healthcare platform announced Tuesday that it has added Zepbound and generic liraglutide to its platform

The state-owned brain chip company plans to implant its experimental device on at least 13 patients by the end of the year

Plus: Chipotle’s avocado hunt

Research shows a dramatic increase in GLP-1 prescriptions among people without diabetes; spending hit nearly $6 billion in 2022

Plus: Chipotle’s avocado hunt

The pharma giants shared new clinical trial results, highlighting potential heart benefits of their meds

Plus: Bill Gates says a 2-day work week is on the way